<DOC>
<DOCNO>
EP-0005864
</DOCNO>
<TEXT>
<DATE>
19791212
</DATE>
<IPC-CLASSIFICATIONS>
A61K-39/29 C12N-7/00 C12N-7/04 <main>A61K-39/29</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
antigenic composition useful as a vaccine or vaccine intermediate, and process for preparing same.
</TITLE>
<APPLICANT>
new york blood center incus<sep>new york blood center, inc.<sep>new york blood center, inc.310 east 67 street new york, new york 10021us<sep>new york blood center, inc.<sep>
</APPLICANT>
<INVENTOR>
prince alfred mayer <sep>vnek john andrew<sep>prince, alfred mayer<sep>vnek, john andrew<sep>prince, alfred mayerstone hill road pound ridgenew york 10576us<sep>vnek, john andrew5133 post road bronxnew york 10471us<sep>prince, alfred mayer  <sep>vnek, john andrew <sep>prince, alfred mayerstone hill road pound ridgenew york 10576us<sep>vnek, john andrew5133 post road bronxnew york 10471us<sep>
</INVENTOR>
<ABSTRACT>
an antigenic composition, useful as a vaccine or vaccine  intermediate, comprising a subparticulate mass containing  hepatitis b surface and hepatitis b e antigens which have a  particle size less than 20 nm, especially less than 5 nm, is  obtained by contacting an antigenic mass containing particles  of hbsag of a particle size of at least 20 nm with a  detergent followed by treating the detergent-containing  antigenic composition with an aqueous aldehyde solution.  
</ABSTRACT>
</TEXT>
</DOC>
